1. Home
  2. ESRT vs SLDB Comparison

ESRT vs SLDB Comparison

Compare ESRT & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Empire State Realty Trust Inc.

ESRT

Empire State Realty Trust Inc.

SELL

Current Price

$4.63

Market Cap

834.5M

Sector

Real Estate

ML Signal

SELL

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$5.52

Market Cap

781.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESRT
SLDB
Founded
2011
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
834.5M
781.7M
IPO Year
2012
2017

Fundamental Metrics

Financial Performance
Metric
ESRT
SLDB
Price
$4.63
$5.52
Analyst Decision
Hold
Strong Buy
Analyst Count
6
14
Target Price
$5.20
★ $18.71
AVG Volume (30 Days)
★ 4.8M
1.4M
Earning Date
11-02-2026
11-02-2026
Dividend Yield
★ 2.96%
N/A
EPS Growth
N/A
★ 34.97
EPS
★ N/A
N/A
Revenue
★ $768,270,000.00
$8,094,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.80
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 0.05
N/A
52 Week Low
$3.93
$3.79
52 Week High
$8.04
$11.45

Technical Indicators

Market Signals
Indicator
ESRT
SLDB
Relative Strength Index (RSI) 58.06 24.03
Support Level $3.95 $5.52
Resistance Level $5.85 $7.42
Average True Range (ATR) 0.16 0.36
MACD 0.07 -0.11
Stochastic Oscillator 69.43 10.71

Price Performance

Historical Comparison
ESRT
SLDB

About ESRT Empire State Realty Trust Inc.

Empire State Realty Trust Inc is a real estate investment trust (REIT) that owns and operates office, retail, and multifamily properties located in New York City, prominently in Manhattan. Its portfolio includes office and retail space as well as residential units. The company's objective is to maximize cash flow and total returns to its shareholders and to increase the value of the properties. Its reportable segments consist of a real estate segment and an Observatory segment. The majority of revenue is derived from the Real Estate segment, which includes all activities related to the ownership, management, operation, acquisition, redevelopment, repositioning and disposition of its traditional real estate assets.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

Share on Social Networks: